- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT02040077
Evaluation of a Computerized Opioid Overdose Prevention Program
Development and Validation of a Computerized Opioid Overdose Intervention.
Studieoversikt
Status
Intervensjon / Behandling
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Maryland
-
Baltimore, Maryland, Forente stater, 21224
- Johns Hopkins University Bayview Medical Campus
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Age (>18yrs old)
- Past yr diagnosis of opioid dependence
- Recent completion of opioid detoxification
Exclusion Criteria:
- Completion of local overdose prevention programs and/or beta-testing of the computerized intervention
- Physical limitations that will prevent adequate seeing/hearing of the intervention, or from using computer
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Forebygging
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Computer + Fluency
Will receive computerized intervention and will be required to periodically demonstrate mastery of information before proceeding to the next module in the computerized intervention.
|
|
|
Aktiv komparator: Computer Only
Will receive computerized intervention but will not be required to demonstrate mastery of information as part of the intervention.
|
|
|
Aktiv komparator: Treatment as Usual
Will receive publicly available pamphlets that contain same information as the computerized intervention.
Will not have access to computerized intervention and will not be required to demonstrate mastery of information as part of the intervention.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Knowledge Gain
Tidsramme: Before the intervention (pre-test) and immediately after the intervention (post-test), an average of 10 minutes.
|
The primary outcome is based on performance in the randomized, controlled trial and is change from baseline on a knowledge test that is administered immediately before and after the intervention. At the time of the study, no validated scales to assess general information regarding overdose in a true/false manner were available. Therefore the study developed a scale for the purpose of measuring knowledge increase. The scale included 51 items, rated as "true", "false", or "I don't know" (to discourage random guessing from resulting in accurate responses accidentally). The answers to all items were included as part of the intervention content so it was possible for every answer to be learned. The scale was summed together as a single measure of number correct responses (range 0-51) with no subscales. Higher values indicated more correct responses. |
Before the intervention (pre-test) and immediately after the intervention (post-test), an average of 10 minutes.
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Percent Participants Who Would Recommend the Intervention to a Family Member or Friend.
Tidsramme: Immediately after the intervention (an average of 10 minutes).
|
Participant willingness (yes or no) to recommend the intervention to a family member or friend.
|
Immediately after the intervention (an average of 10 minutes).
|
Samarbeidspartnere og etterforskere
Sponsor
Samarbeidspartnere
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- Opioid Overdose
- R21DA035327 (U.S. NIH-stipend/kontrakt)
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .